Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Mustafa Suker"'
Autor:
Mohammad Hosein Aziz, Jelle C. van Dongen, Lawlaw Saida, Mustafa Suker, Jeroen L. A. van Vugt, Yordi van Putten, Kostandinos Sideras, Jesse V. Groen, J. Sven D. Mieog, Claudia J. Lucassen, Anneke Droop, Katya Mauff, Shirin Shahbazi Feshtali, Bas Groot Koerkamp, Dana A. M. Mustafa, Casper J. van Eijck
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and AimsFailing immune surveillance in pancreatic ductal adenocarcinoma (PDAC) is related to poor prognosis. PDAC is also characterized by its substantial alterations to patients’ body composition. Therefore, we investigated associations
Externí odkaz:
https://doaj.org/article/85d45099d07041ed98a3c177472deea0
Autor:
Remy Klaassen, Anne Steins, Oliver J. Gurney‐Champion, Maarten F. Bijlsma, Geertjan vanTienhoven, Marc R. W. Engelbrecht, Casper H. J. vanEijck, Mustafa Suker, Johanna W. Wilmink, Marc G. Besselink, Olivier R. Busch, Onno J. deBoer, Marc J. van deVijver, Gerrit K. J. Hooijer, Joanne Verheij, Jaap Stoker, Aart J. Nederveen, Hanneke W. M. vanLaarhoven
Publikováno v:
Molecular Oncology, Vol 14, Iss 9, Pp 2176-2189 (2020)
Patient stratification based on biological variation in pancreatic ductal adenocarcinoma (PDAC) subtypes could help to improve clinical outcome. However, noninvasive assessment of the entire tumor microenvironment remains challenging. In this study,
Externí odkaz:
https://doaj.org/article/b8282aeb68d34baeb5766f9169f10f2d
Autor:
Mustafa Suker, Joost J. Nuyttens, Ferry A.L.M. Eskens, Brigitte C.M. Haberkorn, Peter-Paul L.O. Coene, Erwin van der Harst, Bert A. Bonsing, Alexander L. Vahrmeijer, J.Sven D. Mieog, Rutger Jan Swijnenburg, Daphne Roos, B.Groot. Koerkamp, Casper H.J. van Eijck
Publikováno v:
EClinicalMedicine, Vol 17, Iss , Pp - (2019)
Background: We conducted a multicentre phase II trial to investigate feasibility and antitumor activity of sequential FOLFIRINOX and Stereotactic Body Radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC), (LAPC-1 trial). Met
Externí odkaz:
https://doaj.org/article/a418d643cf42499e991cf16f2da3aa38
Autor:
Eveline E. Vietsch, Ivana Peran, Mustafa Suker, Thierry P. P. van den Bosch, Fleur van der Sijde, Johan M. Kros, Casper H. J. van Eijck, Anton Wellstein
Publikováno v:
Applied Sciences, Vol 9, Iss 22, p 4784 (2019)
Clinical follow-up aided by changes in the expression of circulating microRNAs (miRs) may improve prognostication of pancreatic ductal adenocarcinoma (PDAC) patients. Changes in 179 circulating miRs due to cancer progression in the transgenic KrasG12
Externí odkaz:
https://doaj.org/article/7d3606c65f8944389d568846f4d1858e
Autor:
Jeroen L A van Vugt, Stefan Buettner, Stef Levolger, Robert R J Coebergh van den Braak, Mustafa Suker, Marcia P Gaspersz, Ron W F de Bruin, Cornelis Verhoef, Casper H C van Eijck, Niek Bossche, Bas Groot Koerkamp, Jan N M IJzermans
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186547 (2017)
Low skeletal muscle mass is associated with poor postoperative outcomes in cancer patients. Furthermore, it is associated with increased healthcare costs in the United States. We investigated its effect on hospital expenditure in a Western-European h
Externí odkaz:
https://doaj.org/article/3646f8a6c1fe482682fa1ee8ac2cacbd
Autor:
Jelle C. van Dongen, Eva Versteijne, Bert A. Bonsing, J. Sven D. Mieog, Ignace H.J.T. de Hingh, Sebastiaan Festen, Gijs A. Patijn, Ronald van Dam, Erwin van der Harst, Jan H. Wijsman, Koop Bosscha, Marion van der Kolk, Vincent E. de Meijer, Mike S.L. Liem, Olivier R. Busch, Marc G.H. Besselink, Geertjan van Tienhoven, Bas Groot Koerkamp, Casper H.J. van Eijck, Mustafa Suker
Publikováno v:
van Dongen, J C, Versteijne, E, Bonsing, B A, Mieog, J S D, de Hingh, I H J T, Festen, S, Patijn, G A, van Dam, R, van der Harst, E, Wijsman, J H, Bosscha, K, van der Kolk, M, de Meijer, V E, Liem, M S L, Dutch Pancreatic Cancer Group, Busch, O R, Besselink, M G H, van Tienhoven, G, Groot Koerkamp, B, van Eijck, C H J & Suker, M 2023, ' The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial ', European Journal of Surgical Oncology, vol. 49, no. 4, pp. 811-817 . https://doi.org/10.1016/j.ejso.2022.12.011
European Journal of Surgical Oncology, 49(4), 811-817. W.B. Saunders
European journal of surgical oncology. W.B. Saunders Ltd
European Journal of Surgical Oncology, 49(4), 811-817. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 49(4), 811-817. W.B. Saunders Ltd
European Journal of Surgical Oncology, 49(4), 811-817. W.B. Saunders
European journal of surgical oncology. W.B. Saunders Ltd
European Journal of Surgical Oncology, 49(4), 811-817. ELSEVIER SCI LTD
European Journal of Surgical Oncology, 49(4), 811-817. W.B. Saunders Ltd
BACKGROUND: The necessity of the staging laparoscopy in patients with pancreatic cancer is still debated. The objective of this study was to assess the yield of staging laparoscopy for detecting occult metastases in patients with resectable or border
Autor:
Joost J. Nuyttens, Mustafa Suker, M.A. Teriaca, Mauro Loi, Ferry A.L.M. Eskens, C.H.J. van Eijck
Publikováno v:
Radiotherapy and Oncology, 155, 232-236. Elsevier Ireland Ltd
To report the long-term outcome of a multicenter phase II study with FOLFIRINOX followed by stereotactic body radiotherapy (LAPC-1 trial) in patients with locally advanced pancreatic cancer (LAPC).Patients with histological confirmation of LAPC inope
Publikováno v:
Cancer Radiothérapie, 24(1), 60-63. Elsevier Masson
Hemosuccus Pancreaticus (HP) is a very rare upper gastro-intestinal haemorrhagic event whose causes can be aneurismal lesions, acute and chronic pancreatic inflammatory conditions, and pancreatic masses. We present 2 cases of patients who underwent s
Autor:
Tara M. Mackay, Lennart B. van Rijssen, Jurr O. Andriessen, Mustafa Suker, Geert-Jan Creemers, Ferry A. Eskens, Ignace H. de Hingh, Lonneke V. van de Poll-Franse, Mirjam A.G. Sprangers, Olivier R. Busch, Johanna W. Wilmink, Casper H. van Eijck, Marc G. Besselink, Hanneke W. van Laarhoven
Publikováno v:
Journal of the National Comprehensive Cancer Network, 18(6), 704-711. Cold Spring Publishing LLC
Background: This study sought to assess patient satisfaction and quality of life (QoL) before and after treatment of pancreatic and periampullary cancer. Methods: We conducted a prospective multicenter study of patients treated for pancreatic and per
Autor:
Anne Steins, Onno J. de Boer, Joanne Verheij, Marc G. Besselink, Gerrit K. J. Hooijer, Jaap Stoker, Oliver J. Gurney-Champion, Maarten F. Bijlsma, Mustafa Suker, Olivier R. Busch, Remy Klaassen, Hanneke W. M. van Laarhoven, Casper H.J. van Eijck, Marc J. van de Vijver, Marc R. W. Engelbrecht, Johanna W. Wilmink, Geertjan van Tienhoven, Aart J. Nederveen
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 14, Iss 9, Pp 2176-2189 (2020)
Molecular oncology, 14(9), 2176-2189. Elsevier
Molecular Oncology, 14(9), 2176-2189. John Wiley & Sons Ltd.
Molecular Oncology, Vol 14, Iss 9, Pp 2176-2189 (2020)
Molecular oncology, 14(9), 2176-2189. Elsevier
Molecular Oncology, 14(9), 2176-2189. John Wiley & Sons Ltd.
Patient stratification based on biological variation in pancreatic ductal adenocarcinoma (PDAC) subtypes could help to improve clinical outcome. However, noninvasive assessment of the entire tumor microenvironment remains challenging. In this study,